{"id":"bde07f6e4915","type":"article","url":"https://hartvaat.nl/2026/02/01/richtlijnnaleving-bij-myocardinfarctbehandeling-ingezonden-brief/","title":"Richtlijnnaleving bij myocardinfarctbehandeling — ingezonden brief","title_en":"Guideline Adherence in Myocardial Infarction Treatment","category":"algemeen","category_label":"Algemeen","professions":["cardioloog"],"tags":["myocardinfarct","ouderen","stemi"],"journal":"JAMA Cardiology","doi":"https://jamanetwork.com/journals/jamacardiology/fullarticle/2843039","source_url":"https://doi.org/https://jamanetwork.com/journals/jamacardiology/fullarticle/2843039","authors":[],"significance":4,"published":"2026-02-01","source_date":"2026-02-01","image":"","kennis":["https://hartvaat.nl/kennis/coronairlijden/stemi/"],"congress":"","summary_en":"This letter to the editor discusses the importance of timely primary PCI or pharmacoinvasive therapy for STEMI management, emphasising that reperfusion timing remains the most critical determinant of survival.","created":"2026-07-03T10:25:28Z","updated":"2026-07-03T13:24:52Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Ingezonden brief over het belang van tijdige primaire PCI of farmaco-invasieve strategie bij STEMI-management, naar aanleiding van recente richtlijnaanbevelingen.","abstract_original":"To the Editor On both sides of the Atlantic, the management of ST-segment elevation myocardial infarction (STEMI) has, for more than 15 years, included recommendations for either timely primary percutaneous coronary intervention (pPCI) or pharmacoinvasive therapy (PIT). Although reperfusion strategies have evolved over half a century, timely intervention remains the most critical determinant of survival."}